Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu • (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and tocixology; Alabama Drug Discovery Alliance; Bill L. Harbert Institute for Innovation and Entrepreneurship.
UAB-led research shows how methylating an RNA binding protein leads to alternative RNA splicing. Mutant enzymes are often found in blood cancers.
The Central Alabama Caribbean American Organization shares Caribbean culture and is a resource for area students from the Caribbean.
Joshua Pritchett will take his B.S. degree in computer and information sciences to California and work with burst buffer technology.
UAB Research Administration carefully invests to keep investigators competitive in an era of tight grant funding.
PhishMe is one of America’s fastest-growing private companies; Malcovery staff will remain at Birmingham’s Innovation Depot.
“A major issue facing biomedical research,” says Fran Lund, chair of UAB microbiology.
Validated biomarkers are crucial to developing effective treatments for this degenerative disease.
UAB researchers will enroll patients for prospective studies on pathogenesis of a potentially fatal blood clot disorder with a $2.5 million NIH grant.
Wrong shipment of mice led to estrogen breakthrough in trauma survival.
UAB's strengths in clinical care and research are powering an interdisciplinary expedition into largely uncharted territory: neuroinflammatory mechanisms in Parkinson's disease.